FDA Drug recall D-0303-2020
Sankaijo BOTANICAL LAXATIVE (docusate sodium 8.33 mg and sennosides 1.36 mg) tablets, 150-count bottles, Manufactured by SATO PHARMACEUTICA…
- FDA Drug
- Class III
- terminated
- Published 2019-11-13
On 2019-11-13 the FDA classified a Class III recall of Sankaijo BOTANICAL LAXATIVE (docusate sodium 8.33 mg and sennosides 1.36 mg) tablets, 150-count bottles, Manufactured by SATO PHARMACEUTICA… by Sato Pharmaceutical, citing subpotent Drug: Formulated amount of sennosides component is less than labelled claim.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0303-2020 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2019-10-01 |
| Published | 2019-11-13 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Sato Pharmaceutical |
| Distribution | US |
Product
Sankaijo BOTANICAL LAXATIVE (docusate sodium 8.33 mg and sennosides 1.36 mg) tablets, 150-count bottles, Manufactured by SATO PHARMACEUTICAL CO., LTD., 1-5-27 Motoakasaka Minato-KU Tokyo, Japan; SATO PHARMACEUTICAL, INC., 20695 S. Western Ave., Suite 240, Torrance, CA 90501; NDC 49873-404-01.
Reason
Subpotent Drug: Formulated amount of sennosides component is less than labelled claim.
Identifiers
| ndc | 49873-404-01 |
|---|---|
| code_info | Lot #: TXWT, Exp 01/20; TXTS, Exp 10/20; AXWS, Exp 10/21 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0303-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.